(CELH) Celsius Holdings - Overview

Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NASDAQ (USA) | Market Cap: 7.700m USD | Total Return: -4.9% in 12m

Energy Drinks, Hydration Powders, Wellness Beverages
Total Rating 23
Safety 24
Buy Signal 0.05
Beverages - Non-Alcoholic
Industry Rotation: +10.6
Market Cap: 7.70B
Avg Turnover: 281M
Risk 3d forecast
Volatility59.2%
VaR 5th Pctl9.38%
VaR vs Median-4.10%
Reward TTM
Sharpe Ratio0.12
Rel. Str. IBD4.2
Rel. Str. Peer Group4.5
Character TTM
Beta1.262
Beta Downside1.626
Hurst Exponent0.605
Drawdowns 3y
Max DD77.86%
CAGR/Max DD-0.12
CAGR/Mean DD-0.22
EPS (Earnings per Share) EPS (Earnings per Share) of CELH over the last years for every Quarter: "2021-03": 0.01, "2021-06": 0.0033, "2021-09": -0.0419, "2021-12": 0.0553, "2022-03": 0.03, "2022-06": 0.04, "2022-09": -2.46, "2022-12": -0.28, "2023-03": -0.0916, "2023-06": 0.17, "2023-09": 0.3, "2023-12": 0.17, "2024-03": 0.27, "2024-06": 0.28, "2024-09": -0.0024, "2024-12": -0.13, "2025-03": 0.15, "2025-06": 0.33, "2025-09": -0.3, "2025-12": 0.04, "2026-03": 0.33,
Last SUE: 0.16
Qual. Beats: 0
Revenue Revenue of CELH over the last years for every Quarter: 2021-03: 50.035, 2021-06: 65.073, 2021-09: 94.909, 2021-12: 104.255, 2022-03: 133.388, 2022-06: 154.02, 2022-09: 188.233, 2022-12: 177.964, 2023-03: 259.939, 2023-06: 325.883, 2023-09: 384.757, 2023-12: 347.435, 2024-03: 355.708, 2024-06: 401.977, 2024-09: 265.748, 2024-12: 332.197, 2025-03: 329.276, 2025-06: 739.259, 2025-09: 725.106, 2025-12: 721.628, 2026-03: 782.615,
Rev. CAGR: 38.68%
Rev. Trend: 89.9%
Last SUE: 0.32
Qual. Beats: 0

Warnings

Beneish M-Score -0.49 > -1.5 - likely earnings manipulation

Tailwinds

No distinct edge detected

Description: CELH Celsius Holdings

Celsius Holdings, Inc. (CELH) specializes in the development and global distribution of functional energy drinks and hydration products. Its portfolio includes ready-to-drink beverages and powder sticks marketed under the CELSIUS brand, alongside distribution partnerships for other wellness-focused labels. The company utilizes a multi-channel distribution strategy encompassing major retailers, fitness centers, and e-commerce platforms.

The energy drink sector is characterized by high consumer loyalty and a shift toward clean-label ingredients, such as green tea and ginger, which Celsius integrates into its proprietary formulas. Unlike traditional soft drink companies, functional beverage firms often rely on a hybrid distribution model that combines direct-to-store delivery with independent wholesale networks to maximize shelf presence.

Investors can further examine these market dynamics and financial metrics on ValueRay.

Headlines to Watch Out For
  • PepsiCo distribution partnership efficiency drives market share gains and margin expansion
  • Inventory rebalancing at major distributors impacts short-term revenue growth projections
  • International market penetration scales global sales beyond the core North American segment
  • Category competition from incumbent energy brands pressures shelf space and pricing power
  • Consumer shift toward functional wellness beverages sustains long-term volume demand trends
Piotroski VR-10 (Strict) 5.0
Net Income: 173.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -5.39 > 1.0
NWC/Revenue: 25.72% < 20% (prev 74.75%; Δ -49.03% < -1%)
CFO/TA 0.06 > 3% & CFO 329.8m > Net Income 173.7m
Net Debt (1.91b) to EBITDA (283.4m): 6.73 < 3
Current Ratio: 1.73 > 1.5 & < 3
Outstanding Shares: last quarter (259.8m) vs 12m ago 9.53% < -2%
Gross Margin: 49.62% > 18% (prev 0.50%; Δ 4.91k% > 0.5%)
Asset Turnover: 84.61% > 50% (prev 71.48%; Δ 13.13% > 0%)
Interest Coverage Ratio: 4.07 > 6 (EBITDA TTM 283.4m / Interest Expense TTM 60.8m)
Altman Z'' 1.69
A: 0.15 (Total Current Assets 1.81b - Total Current Liabilities 1.05b) / Total Assets 5.16b
B: 0.05 (Retained Earnings 272.0m / Total Assets 5.16b)
C: 0.07 (EBIT TTM 247.4m / Avg Total Assets 3.51b)
D: 0.07 (Book Value of Equity 273.7m / Total Liabilities 3.91b)
Altman-Z'' = 1.69 = BB
Beneish M -0.49
DSRI: 1.45 (Receivables 832.4m/256.4m, Revenue 2.97b/1.33b)
GMI: 1.02 (GM 49.62% / 50.43%)
AQI: 3.18 (AQ_t 0.63 / AQ_t-1 0.20)
SGI: 2.23 (Revenue 2.97b / 1.33b)
TATA: -0.03 (NI 173.7m - CFO 329.8m) / TA 5.16b)
Beneish M = -0.49 (Cap -4..+1) = D
What is the price of CELH shares?

As of May 29, 2026, the stock is trading at USD 33.22 with a total of 10,265,743 shares traded.
Over the past week, the price has changed by +16.03%, over one month by +1.84%, over three months by -38.03% and over the past year by -4.90%.

Is CELH a buy, sell or hold?

Celsius Holdings has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CELH.

  • StrongBuy: 8
  • Buy: 6
  • Hold: 6
  • Sell: 1
  • StrongSell: 0

What are the forecasts/targets for the CELH price?
Analysts Target Price 62 86.6%
Celsius Holdings (CELH) - Fundamental Data Overview as of 26 May 2026
Market Cap USD = 7.70b (7.70b USD * 1.0 USD.USD)
P/E Trailing = 70.0465
P/E Forward = 20.202
P/S = 2.5938
P/B = 6.1562
P/EG = 0.3115
Revenue TTM = 2.97b USD
EBIT TTM = 247.4m USD
EBITDA TTM = 283.4m USD
Long Term Debt = 668.9m USD (from longTermDebt, last quarter)
Short Term Debt = 7.00m USD (from shortTermDebt, last quarter)
Debt = 2.46b USD (from shortLongTermDebtTotal, last quarter) + Leases 19.7m
Net Debt = 1.91b USD (calculated: Debt 2.46b - CCE 549.2m)
Enterprise Value = 9.61b USD (7.70b + Debt 2.46b - CCE 549.2m)
Interest Coverage Ratio = 4.07 (Ebit TTM 247.4m / Interest Expense TTM 60.8m)
EV/FCF = 32.81x (Enterprise Value 9.61b / FCF TTM 292.8m)
FCF Yield = 3.05% (FCF TTM 292.8m / Enterprise Value 9.61b)
FCF Margin = 9.86% (FCF TTM 292.8m / Revenue TTM 2.97b)
Net Margin = 5.85% (Net Income TTM 173.7m / Revenue TTM 2.97b)
Gross Margin = 49.62% ((Revenue TTM 2.97b - Cost of Revenue TTM 1.50b) / Revenue TTM)
Gross Margin QoQ = 48.31% (prev 47.37%)
Tobins Q-Ratio = 1.86 (Enterprise Value 9.61b / Total Assets 5.16b)
Interest Expense / Debt = 2.48% (Interest Expense 60.8m / Debt 2.46b)
Taxrate = 19.95% (27.4m / 137.5m)
NOPAT = 198.1m (EBIT 247.4m * (1 - 19.95%))
Current Ratio = 1.73 (Total Current Assets 1.81b / Total Current Liabilities 1.05b)
Debt / Equity = 1.96 (Debt 2.46b / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = 6.73 (Net Debt 1.91b / EBITDA 283.4m)
Debt / FCF = 6.51 (Net Debt 1.91b / FCF TTM 292.8m)
Total Stockholder Equity = 2.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.95% (Net Income 173.7m / Total Assets 5.16b)
RoE = 7.51% (Net Income TTM 173.7m / Total Stockholder Equity 2.31b)
RoCE = 8.30% (EBIT 247.4m / Capital Employed (Equity 2.31b + L.T.Debt 668.9m))
RoIC = 4.82% (NOPAT 198.1m / Invested Capital 4.11b)
WACC = 8.38% (E(7.70b)/V(10.2b) * Re(10.42%) + D(2.46b)/V(10.2b) * Rd(2.48%) * (1-Tc(0.20)))
Discount Rate = 10.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 26.26 | Cagr: 5.19%
[DCF] Terminal Value 77.87% ; FCFF base≈258.0m ; Y1≈295.7m ; Y5≈435.2m
[DCF] Fair Price = 18.03 (EV 6.52b - Net Debt 1.91b = Equity 4.61b / Shares 255.6m; r=8.38% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.16 | # QB: 0
Revenue Correlation: 89.91 | Revenue CAGR: 38.68% | SUE: 0.32 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.43 | Chg30d=-7.47% | Revisions=-47% | Analysts=17
EPS next Quarter (2026-09-30): EPS=0.44 | Chg30d=-10.40% | Revisions=-70% | Analysts=17
EPS current Year (2026-12-31): EPS=1.63 | Chg30d=+0.62% | Revisions=+10% | GrowthEPS=+21.5% | GrowthRev=+33.1%
EPS next Year (2027-12-31): EPS=2.04 | Chg30d=+0.40% | Revisions=+5% | GrowthEPS=+25.3% | GrowthRev=+9.8%
[Analyst] Revisions Ratio: -70%